Jody Dushay, an assistant professor of medicine at Harvard Medical School and an attending physician in endocrinology at Beth Israel Deaconess Medical Center, who prescribes weight-loss medications
Signs that insulin may be needed include persistently elevated blood sugar despite maximum GLP-1 doses, declining endogenous insulin production, and treatment plateaus that suggest the incretin-based approach has reached its limits
NativePath positions it as nutritional support for structural health during periods of increased demand: significant weight loss, aging-related collagen decline, or both
That exhaustion isn't laziness or "adjusting to the medication"it's electrolyte depletion, and it shows up within 4872 hours of starting treatment or increasing your dose
Dehydration worsens nausea and can cause headaches that amplify the perceived side effect burden
Retatrutide Timeline Eli Lillys Phase 3 program for Retatrutide includes multiple trials examining efficacy for obesity and type 2 diabetes